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The Osteoclast Differentiation Factor
Osteoprotegerin-Ligand Is Essential
for Mammary Gland Development
dinated resorption by osteoclasts. The TNF family mole-
cule Osteoprotegerin-ligand (OPGL; also known as ODF,
TRANCE, and RANKL) (Anderson et al., 1997; Wong et
al., 1997; Lacey et al., 1998; Yasuda et al., 1998) is a
key factor stimulating the differentiation and activation
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involved in reproduction and lactation such as prolactinOsteoprotegerin-ligand (OPGL) is a key osteoclast dif-
and parathyroid hormone-related peptide (PTHrP) (Kar-ferentiation/activation factor essential for bone re-
senty, 1999). Reduction of ovarian function followingmodeling. We report that mice lacking OPGL or its
menopause in women, and ovariectomy in animal mod-receptor RANK fail to form lobulo-alveolar mammary
els, result in osteoporosis and fractures, conditions thatstructures during pregnancy, resulting in death of
can be completely reversed, at least in animals, by treat-newborns. Transplantation and OPGL-rescue experi-
ment with OPG (Simonet et al., 1997). The evolutionaryments in opgl2/2 and rank2/2 pregnant females showed
and functional rationale for OPGL/OPG regulation bythat OPGL acts directly on RANK-expressing mam-
reproductive hormones and the prevalence of hormon-mary epithelial cells. The effects of OPGL are autono-
ally regulated and gender biased osteoporosis in oldermous to epithelial cells. The mammary gland defect
females is not known.in female opgl2/2 mice is characterized by enhanced
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tating mammary gland. Mammary gland morphogenesisrecombinant OPGL treatment. These data provide a
proceeds in distinct steps, beginning with a fetal mam-novel paradigm in mammary gland development and
mary anlage that undergoes ductal elongation andan evolutionary rationale for hormonal regulation and
branching (Robinson et al., 1999). Mammary branchinggender bias of osteoporosis in females.
commences with puberty and leads to infiltration of the
epithelial ductal tree into the mammary fat pad. DuringIntroduction
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opment of lobulo-alveolar structures result from theThe morphogenesis and remodeling of bone requires
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Mothers meet the increased requirements for calcium sessed by histological examination and immunohisto-
chemical determination of smooth muscle actin expres-during pregnancy and lactation by doubling their intesti-
nal calcium absorption and demineralizing their skele- sion. As in the wild type, these cells were localized to
the basal surfaces of the epithelial ducts (inset in Figuretons via activation of bone-resorbing osteoclasts (Ko-
vacs and Kronenberg, 1997). 2B). These results indicate that the absence of OPGL
expression has no apparent effect on the developmentWe report that pregnancy hormones induce OPGL
expression in mammary epithelial cells. OPGL expres- of the parenchymal breast tissue during postnatal life,
puberty, or in nulliparous adult female mice. The rate ofsion is required for cellular survival/proliferation. Muta-
tions of the opgl or rank genes result in the total inhibition ductal side branching during puberty needs to be further
analyzed in opgl2/2 mice.of lobulo-alveolar epithelial development and a com-
plete block in the formation of a lactating mammary Since morphogenesis of the ductal tree appeared nor-
mal in nulliparous opgl2/2 females, we hypothesized thatgland, leading to the death of newborn pups. Local re-
constitution of OPGL in opgl2/2 mammary tissue, but loss of OPGL might affect mammary gland development
during pregnancy. In wild-type females, pregnancy hor-not in rank2/2 mammary glands, restores epithelial prolif-
eration, lobulo-alveolar development, and mammary mones induce proliferation of ductal epithelium and
sprouting of alveolar buds in mid-pregnancy (Figuresgland formation during pregnancy. Thus, OPGL and
RANK, the master regulators of skeletal calcium release, 1C and 2C). Proliferation and terminal differentiation of
the alveolar buds follows, resulting in fully developedare essential for the formation of the lactating mammary
gland, the organ required for transmission of maternal lobulo-alveolar structures and dilated primary ducts at
one day lactation (L1) (Figures 1E and 2E). In the mam-calcium to neonates in mammalian species.
mary glands of pregnant opgl2/2 females, increased duc-
tal side branching and formation of the initial alveolarResults
buds occurred normally (Figures 1D and 2D), indicating
that OPGL is not involved in these processes. However,Essential Role of OPGL in the Formation
differentiation and expansion of the alveolar buds intoof Lobulo-Alveolar Mammary
mature lobulo-alveolar mammary structures was com-Structures in Pregnancy
pletely arrested in opgl2/2 females. The earliest defectsSince OPGL expression was known to be regulated by
in alveolar development in pregnant female opgl2/2 micesex and reproductive hormones (Karsenty, 1999; Rood-
were observed on day 14.5 of pregnancy (P14.5) (Figureman, 1999; Ross, 2000), we investigated whether OPGL
1D), and these defects remained evident until lactationfunction was required during pregnancy and lactation.
(Figure 1F). Nevertheless, at lactation, the mammaryAlthough opgl2/2 mothers are osteopetrotic and display
glands of opgl2/2 mice displayed the usual dilation ofa failure in tooth eruption, they are fertile and give birth to
primary ducts (Figure 2F; compare to ducts at P14.5 inlitters of morphologically normal pups whose numbers
Figure 2D) indicating that luminal expansion of epithelialwere comparable to those of opgl1/2 and opgl1/1 moth-
ducts is not affected by the absence of OPGL. In additioners. However, despite normal nursing and mothering
to the defect in lobulo-alveolar development, expressioncharacteristics displayed by opgl2/2 females and suck-
of mRNA for the major milk protein b-casein was signifi-ling attempts made by their pups, newborns of opgl2/2
cantly impaired starting at P14.5 and continuing until atmothers failed to thrive and all pups died within 48 hr
least day one of lactation (L1; Figure 2G). Therefore, theof birth. Lethality of the newborns was independent of
death of pups born to opgl2/2 females appears to betheir genotype (opgl1/2 or opgl2/2). Examination of one-
the consequence of inappropriate mammary glandularday-old pups revealed that they lacked milk in their
growth and a failure in maternal milk production. Thesestomachs. Fostering by surrogate wild-type females res-
data show that OPGL expression is essential for thecued the survival of both opgl1/2 and opgl2/2 pups born
development of the initial mammary alveolar buds intoto opgl2/2 females. These data suggested that opgl2/2
mature lobulo-alveolar epithelial structures, and the for-mothers might have a defect in the production of breast
mation and differentiation of a functional, milk-produc-milk.
ing mammary gland.Defective milk production can be caused by various
developmental and/or functional abnormalities in the
mammary glands. Mammary gland morphogenesis pro- OPGL Is Necessary for Mammary Gland
Development during Pregnancyceeds in distinct steps, beginning with a fetal mammary
anlage that undergoes ductal elongation and branching The defect in lobulo-alveolar development in pregnant
opgl2/2 females could point to a primary role for OPGL(Robinson et al., 1999). Mammary branching commen-
ces with puberty and leads to infiltration of the epithelial in mammary tissue development, or might be secondary
to systemic endocrine abnormalities. We therefore de-ductal tree into the mammary fat pad. In age-matched
nulliparous opgl2/2, opgl1/2 , and opgl1/1 females, forma- termined whether local reconstitution of opgl2/2 mam-
mary tissue with recombinant mouse OPGL (rOPGL)tion of the mammary gland anlage, elongation and ex-
tension of the ductal tree, as well as ductal side could rescue lobulo-alveolar development. Slow-release
pellets containing soluble rOPGL were implanted intobranching were comparable (Figures 1A and 1B). Histo-
logical analyses of nulliparous mammary tissues at dif- the mammary glands of nonpregnant and pregnant fe-
males. To first determine if soluble rOPGL could induceferent time points after birth showed that the epithelial
ductal structures of opgl2/2 mice were of the usual size ductal and/or alveolar differentiation in the absence of
pregnancy, we implanted rOPGL-containing pellets intoand surrounded by normal stromal matrix and fibro-
blasts (Figures 2A and 2B). Importantly, opgl2/2 mice one mammary fat pad of nulliparous, nonpregnant wild-
type females, and control pellets containing the vehiclecontained normal numbers of myoepithelial cells, as as-
OPGL in Mammary Gland Development
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Figure 1. Essential Role of OPGL in the Formation of Lobulo-Alveo-
lar Mammary Structures in Pregnancy
Whole-mount analyses of mammary tissue of (A) nulliparous wild-
type females; (B) nulliparous opgl2/2 females; (C) wild-type females
at P14.5; (D) opgl2/2 females at P14.5; (E) wild-type females at L1;
and (F) opgl2/2 females at L1. Mammary gland ductal morphogenesis
appears normal in nulliparous opgl2/2 females (A and B). Alveoli in
gestating wild-type females (arrowhead in C) have progressed to
form lobular structures, whereas development is arrested at a rudi-
mentary alveolar bud in opgl2/2 females (arrowheads in D). Lobulo-
alveolar structures (asterisks in E) in wild-type females at L1 encom-
pass the whole mammary fat-pad. In contrast, opgl2/2 mammary Figure 2. Impaired Development of Mammary Lobulo-Alveolar
tissue is devoid of lobulo-alveolar structures at L1 (F) and resembles Structures in opgl2/2 Females
that at P14.5 (D). Scale bars: (A)–(F) 0.5 mm.
(A–F) Histological appearance of mammary tissue of (A) nulliparous
wild-type females; (B) nulliparous opgl2/2 females; (C) wild-type fe-
males at P14.5; (D) opgl2/2 females at P14.5; (E) wild-type females
alone into the contralateral mammary fat pad of the at L1; and (F) opgl2/2 females at L1. Arrowhead in inset of (B) shows
the normal appearance of myoepithelial cells surrounding the epi-same mice. Local administration of rOPGL did not in-
thelial ducts in opgl2/2 mammary tissue as assessed by immunoper-duce proliferation, elongation, ductal side-branching, or
oxidase staining for smooth muscle actin. Alveolar development isalveolar bud formation in nonpregnant animals (not
arrested at a rudimentary alveolar bud in opgl2/2 females (arrow-
shown). heads in D). Note that primary ducts (arrowheads in F) are enlarged
However, when rOPGL pellets were implanted into the in opgl2/2 females at L1 as compared to P14.5 (D). These enlarged
mammary tissues of pregnant opgl2/2 females, lobulo- ducts at L1 contain lipid droplets and often contain CD451 leuko-
cytes (arrow in F). The distribution and number of CD451 leukocytesalveolar development was rescued (Figures 3A–3D), in
adjacent to the myoepithelial mammary tissue was comparable be-that the morphological appearance of lobulo-alveolar
tween wild-type and opgl2/2 nulliparous females and females atstructures was comparable to that of pregnant wild-type
P14.5. H&E stainings. Scale bars: (A)–(F) 25 mm; (B) insert, 25 mm;
females (Figure 3B to Figure 1E). Moreover, local im- inserts in (C)–(F) 0.1 mm.
plantation of rOPGL restored the expression of b-casein (G) Expression of the milk protein b-casein. Total RNA was isolated
mRNA (Figure 2G), indicating a recovery of milk produc- at P14.5 and L1 from mammary tissues of wild type (opgl1/1) females,
opgl2/2 females, and two different opgl2/2 females implanted withtion. In contrast, implantation of control pellets into the
pellets containing rOPGL [10 mg/pellet] (rOPGL). A representativecontralateral mammary tissue of the same pregnant
Northern blot of b-casein and keratin 18 mRNA expression is shown.ogpl2/2 females did not restore lobulo-alveolar develop-
ment, and mammary gland formation remained blocked
at the alveolar bud stage (Figures 3A and 3C). These
local administration of rOPGL restores lobulo-alveolarresults indicate that the developmental arrest of opgl2/2
development in the mammary gland.mammary glands is directly due to a lack of OPGL. It
should be noted that ovulation and subsequent luteal
growth in the ovaries, development and differentiation The Effect of OPGL Is Autonomous
to Epithelial Cellsof uteri, as well as trophoblastic implantation are compa-
rable among opgl2/2, opgl1/2 , and opgl1/1 females, indi- Mammary gland development is controlled by an inter-
play between epithelial and stromal cells (Robinson etcating that OPGL has no effect on these tissues. Thus,
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rous mammary epithelial tissues were transplanted into
cleared mammary fat pads of nulliparous rag12/2 fe-
males (Robinson et al., 2000). Rag12/2 mice lack T and
B cells and do not reject the epithelial transplants. The
contralateral fat pad of the transplanted animals was
left untreated. Rag12/2 animals that carried transplanted
opgl1/1 or opgl2/2 mammary epithelium were mated and
mammary gland development was examined (Figures
3E–3H). At lactation, the development of opgl1/1 tissue
transplanted into rag12/2 females (Figure 3F) paralleled
that of the nontransplanted control gland (Figure 3E),
and the fat-pads of both glands were filled with lobulo-
alveolar structures exhibiting secretory activity. How-
ever, mammary gland development was arrested at the
alveolar bud stage when opgl2/2 epithelium was trans-
planted into rag12/2 mammary stroma (Figure 3H). It
should be noted that although rag12/2 stroma did not
rescue lobulo-alveolar development of opgl2/2 epithe-
lium, it was able to support elongation and side-
branching of opgl2/2 ductal epithelial cells (Figure 3H).
These transplantation studies show that the lobulo-alve-
olar differentiation defect in pregnant opgl2/2 females is
inherent and cell autonomous to mammary epithelial
cells and cannot be overcome by the presence of wild-
type stroma. Thus, local OPGL is essential for the devel-
opment of a mammary gland during pregnancy.
Loss of RANK Phenocopies opgl Deficiency
in Mammary Tissue
RANK is a member of the TNFR family that acts as a
receptor for OPGL on osteoclasts and dendritic cells
(Anderson et al., 1997; Hsu et al., 1999). Mice with muta-
tions in rank have defects in osteoclastogenesis andFigure 3. OPGL Protein Restores Mammary Gland Development in
Pregnant opgl2/2 Females lymph node formation (Dougall et al., 1999; Li et al.,
(A–D) Rescue of lobulo-alveolar development in pregnant opgl2/2 2000) that are identical to those we have previously
females by rOPGL. (A,C) Control pellets and (B and D) pellets con- reported for opgl2/2 mice (Kong et al., 1999a). However,
taining rOPGL [10 mg/pellet] were implanted into contralateral mam- opgl2/2 mice also show defects in T cell development
mary glands of opgl2/2 females at P14.5. Mammary glands were
that are not found in rank2/2 mice, suggesting that OPGLanalyzed at L1. Lobulo-alveolar development (arrowhead in D) pro-
may associate with another receptor. To test whetherceeds normally in pregnant opgl2/2 mice implanted with rOPGL,
OPGL’s role in mammary gland formation is mediatedwhereas the development of these structures is not rescued in the
control contralateral mammary glands of the same mouse (arrow- by RANK, or by another as yet unidentified receptor, we
heads in A and C). analyzed mammary gland development in rank2/2 female
(E-H) opgl1/1 and opgl2/2 mammary epithelial tissues were trans- mice that are osteopetrotic and display a failure in tooth
planted into cleared fat-pads of rag12/2 females prior to pregnancy.
eruption (Li et al., 2000). Like opgl2/2 mothers, rank2/2(E and G) Normal development of lobulo-alveolar structures in non-
mothers are fertile and give birth to litters of morphologi-transplanted mammary glands of rag12/2 females. (F) rag12/2 stroma
cally normal pups whose numbers were comparable tosupports the development into normal lobulo-alveolar structures of
opgl1/1 mammary epithelial cells transplanted in the contralateral those of opgl1/2 and opgl1/1 mothers. However, after
mammary gland of the same mouse as in (E). (H) rag12/2 stroma giving birth, rank2/2 females failed to lactate and their
fails to rescue lobulo-alveolar development (arrowheads) of opgl2/2 litters did not survive, despite normal nursing and suck-
mammary epithelial cells transplanted into the contralateral mam-
ling behaviors displayed by mothers and pups.mary gland of the same mouse as in (G). Data from analyses at L1
Formation of the mammary gland anlage, elongationare shown. Scale bars: (A) and (B), 0.5 mm; (C)–(H), 50 mm; inserts
and extension of the ductal tree, and ductal sidein (C)–(H), 0.1 mm.
branching were comparable between age-matched nul-
liparous rank2/2, rank1/2 , and rank1/1 mice (Figures 4A–
4C, and data not shown). Thus, neither OPGL nor RANKal., 1999). Since the slow-release rOPGL pellets could
possibly override and mask essential epithelial-stromal is required for mammary gland development before
pregnancy. In pregnant rank2/2 females, the initial alveo-interactions, the impaired mammary gland development
in opgl2/2 mice could be due to defects in stromal cells lar buds sprouted but differentiation and expansion of
these buds into mature lobulo-alveolar mammary struc-and/or a cell-autonomous defect localized to the epithe-
lial cells. Thus, we evaluated whether opgl1/1 stromal tures was completely abolished (Figures 4D, 4E, 4G, and
4H). Importantly, whereas implantation of rOPGL into thetissue could induce opgl2/2 epithelial cells to form lo-
bulo-alveolar structures during pregnancy. To separate mammary tissues of pregnant opgl2/2 females restored
lobulo-alveolar differentiation (Figures 3A–3D) and milkstromal from epithelial signals, opgl1/1 or opgl2/2 nullipa-
OPGL in Mammary Gland Development
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Figure 4. rank2/2 Mammary Tissue Phenocopies Defects in opgl2/2 Mammary Tissue
(A–C) Normal mammary ductal morphogenesis in nulliparous wild-type (A) and rank2/2 (B,C) female mice. Inset in (C) is a low power magnification
showing normal branching morphogenesis.
(D,G) Typical development of lobulo-alveolar structures at lactation in wild-type tissue. (E,H) Absence of lobulo-alveolar development in
pregnant rank2/2 females. Development is arrested at the initial alveolar bud stage (arrowheads), as occurs in opgl2/2 females. (F and I)
Resistance of the lobulo-alveolar defect to rescue by implantation of rOPGL-containing pellets [10 mg/pellet] into pregnant rank2/2 females.
Only alveolar buds (arrowheads) are detectable. Representative whole mount stainings and H&E stained sections are shown at L1. Scale bars:
(A), (B), (D), and (F), 0.5 mm; (C), and (G–I), 50 mm; inserts in (C) and (G–I), 0.1 mm.
production (Figure 2G), implantation of rOPGL into the lished reports on the expression of OPGL and RANK
in normal human mammary tissue, we determined themammary tissues of pregnant rank2/2 mice did not res-
cue the mammary defects (Figure 4F and 4I). Thus, preg- levels and kinetics of OPGL and RANK expression, as
well as the cellular localization of these molecules, innant rank2/2 females display defects in mammary gland
development that are phenocopies of those in pregnant mammary tissues of nulliparous wild-type females and
at different stages of pregnancy. Expression of OPGLopgl2/2 mice. These results show that expression of both
OPGL and RANK is essential for differentiation of mam- protein in mammary tissue was evident as early as P12.5
and gradually increased to maximal expression at L1mary alveolar cells during pregnancy, and that OPGL
functions through RANK alone to mediate lobulo-alveo- (Figure 5A). OPGL protein could not be detected in nul-
liparous mammary tissue undergoing active ductal de-lar morphogenesis in preparation for lactation.
velopment in a 5-week-old mouse (Figure 5A) or in mam-
mary tissue of adult nonpregnant females (not shown).Hormone-Induced Expression and In Situ
Localization of OPGL and RANK Because OPGL is not expressed in the mammary tis-
sue of nonpregnant females but is strongly induced dur-OPGL is expressed in lymph nodes, spleen, thymus,
intestinal lymphoid patches, and in areas of active bone ing pregnancy, we hypothesized that OPGL expression
might be regulated by pregnancy hormones. Progester-remodeling in the skeleton, primitive mesenchymal cells
surrounding the cartilaginous anlagen, hypertrophying one, estrogen, prolactin, and PTHrP are systemically
upregulated during pregnancy and are essential for bothchondrocytes, and activated T cells (Wong et al., 1997;
Lacey et al., 1998). RANK is expressed on hematopoietic pregnancy and lactation (Ormandy et al., 1997; Couse
and Korach, 1998; Dunbar and Wysolmerski, 1999;osteoclast progenitors, mature osteoclasts, chondro-
cytes, endothelial cells of large arterial blood vessels, Horseman, 1999). These hormones were individually in-
jected into nonpregnant, nulliparous female mice andand dendritic cells of the immune system (Anderson et
al., 1997; Hsu et al., 1999). It has also been reported OPGL and RANK expression in the mammary tissues
was examined by RT-PCR and Western blotting. Expres-that RANK is expressed on some human breast cancer
cell lines (Thomas et al., 1999). In the absence of pub- sion of OPGL mRNA (not shown) and protein (Figure
Cell
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sion in ovariectomized female mice that do not produce
ovarian-derived estrogen or progesterone. In contrast
to the inducible expression of OPGL, RANK mRNA was
found to be constitutively expressed in the mammary
tissue of nonpregnant females and at all stages of preg-
nancy and lactation analyzed (not shown).
In situ mRNA hybridization studies showed that ex-
pression of OPGL was restricted to mammary epithelial
cells both at P12.5 (Figures 5C and 5D) and L1 (Figures
5E and 5F). Interestingly, at P12.5, OPGL mRNA was
most strongly expressed in the developing alveolar buds
but OPGL mRNA was not detected in ductal epithelial
cells. Similarly to OPGL expression, RANK mRNA ex-
pression was localized to epithelial cells at P12.5 (Fig-
ures 5G and 5H) and L1 (Figures 5I and 5J). At day 12.5
of pregnancy, RANK mRNA is abundantly expressed in
ductal and alveolar bud epithelium (Figure 5G). At L1,
both OPGL and RANK are highly expressed in lobulo-
alveolar epithelial cells (Figures 5E and 5I). These data
show that pregnancy hormones induce OPGL in mam-
mary epithelial cells whereas RANK is constitutively ex-
pressed on the same or a neighboring epithelial cell.
OPGL Is Required for Proliferation and Survival
of Mammary Epithelial Cells
What is the mechanism of impaired lobulo-alveolar dif-
ferentiation in opgl2/2 and rank2/2 mice? During preg-
nancy in wild-type females, increased ductal side
branching and development of lobulo-alveolar struc-
tures result from the expansion and proliferation of duc-
tal and alveolar epithelium (Neville, 1999). opgl2/2 and
rank2/2 mice show rudimentary alveolar development
and form the initial alveolar buds, suggesting that OPGL
does not initiate mammary differentiation. Rather, im-
paired alveolar epithelial cell proliferation and/or exces-
sive cell death occurring as the gland tries to form lobu-
lar-alveolar structures might result in the observed
defects.
To address this issue, the status of epithelial prolifera-
tion was assessed by in situ immunostaining for prolifer-Figure 5. OPGL and RANK Expression in Mammary Tissues
ating cell nuclear antigen (PCNA). The proliferation index(A) OPGL protein expression in mammary glands of a 5-week-old
(PI) was defined as the number of PCNA-positive nucleinulliparous control female (C), at different days of pregnancy (P4.5-
P18.5) and L1. OPGL expression was detected by Western blotting. of alveolar epithelial cells/total nuclei. The proliferation
One result representative of three experiments is shown. of alveolar bud epithelium was significantly reduced in
(B) Induction of OPGL in mammary glands in response to hormones. opgl2/2 females compared to the wild-type. Implantation
Nulliparous wild-type females were ovarectomized and injected with
of control pellets (Figures 6A and 6C) did not rescuePBS (control, C), progesterone (P), prolactin (Prl), 17-b-estradiol (E2),
epithelial proliferation and the number of PCNA-positiveor PTHrP. OPGL expression in mammary tissues was determined by
cells remained similar to that in nonmanipulated preg-Western blotting 24 hr after the initial injection. A representative
India ink control is shown. nant opgl2/2 mice (PI 5 16 6 4.9 versus 21 6 6.1, respec-
(C–J) In situ hybridization to localize (C–F) OPGL mRNA and (G–J) tively). Implantation of rOPGL-containing pellets re-
RANK mRNA expression at P12.5 and L1. Expression of both OPGL stored PCNA expression in alveolar epithelial cells of
and RANK mRNA is restricted to epithelial cells. (C and D) Expres-
pregnant opgl2/2 mice (PI 5 62 6 6.7; Figures 6B andsion of OPGL in the alveolar bud epithelium at P12.5 (arrowheads).
6D) to the level observed in pregnant wild-type miceAt day P12.5, RANK mRNA is abundantly expressed in ductal (arrow
(PI 5 57 6 4.5). Induction of alveolar epithelial prolifera-in H) and alveolar bud epithelium (arrowhead in H). (E and I) At
L1, both OPGL and RANK are highly expressed in lobulo-alveolar tion by rOPGL in opgl 2/2 females is clearly evident in
epithelial cells (arrowheads). (C), (E), (G), and (I) were hybridized to alveolar buds (Figure 6D) when contrasted to impaired
antisense and (D), (F), (H), and (J) to sense (control) riboprobes. (C) PCNA in the rudimentary alveolar buds of the contralat-
and (D) are 35S -UTP and (E)–(J) are DIG-UTP in situ hybridizations.
eral control mammary tissue (Figure 6C). In contrast toScale bars: 50 mm.
alveolar epithelium, the proliferation of ductal epithelial
cells was comparable between opgl1/1 and opgl2/2 non-
transplanted females both at P14.5 (PI 5 18 6 2.8 versus5B) was strongly induced by progesterone, prolactin,
or PTHrP, but not by 17-b-estradiol. Furthermore, both 19 6 4.2, respectively) and at L1 (PI 5 20 6 6.3 versus
17 6 3.9). Implantation of rOPGL had no apparent influ-prolactin and PTHrP were able to induce OPGL expres-
OPGL in Mammary Gland Development
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ence on the proliferation of ductal epithelial cells in preg-
nant opgl2/2 mice. These data indicate that OPGL is a
critical regulator of alveolar epithelial cell proliferation.
Because OPGL has been shown to provide survival
signals to osteoclasts and dendritic cells (Anderson et
al., 1997; Wong et al., 1999), we analyzed the apoptosis
of mammary epithelial cells in the presence and absence
of OPGL (Figures 6E–6G). No apoptotic epithelial cells
were detected in ductal and alveolar tissues of wild-type
mammary glands throughout pregnancy. In contrast,
apoptotic cells were readily detected among mammary
epithelial cells from opgl2/2 females both at P14.5 (not
shown) and L1 (Figure 6G). The increased apoptosis
occurred primarily in the epithelium of alveolar buds
(Figure 6E), although minimal (,0.5%) cell death was
also observed in opgl2/2 ductal epithelium (Figure 6G).
Implantation of rOPGL pellets markedly reduced apo-
ptosis in opgl2/2 alveolar epithelium, whereas contralat-
eral implantation of control pellets (ctrl) did not (Figures
6E–6G). These results indicate that loss of OPGL expres-
sion results in increased apoptosis of mammary alveolar
epithelial cells during pregnancy, but can be rescued
by rOPGL. Thus, OPGL is required for proliferation and
survival of mammary alveolar epithelial cells during
pregnancy.
Impaired PKB/Akt Activation in opgl2/2
Mammary Epithelial Cells
The above data suggested that OPGL is a crucial sur-
vival factor for alveolar epithelium, prompting us to ex-
amine the expression and activation status of the anti-
apoptotic molecule PKB/Akt in opgl2/2 mammary tissue.
In situ immuno-localization studies showed that phos-
phorylated serine 473 of PKB/Akt (indicative of active
PKB/Akt) was not detectable in nonpregnant tissues of
wild type mice (not shown). However, PKB/Akt phos-
phorylation did occur in wild type mammary epithelial
cells during pregnancy (not shown) and at lactation (Fig-
ures 7A and 7B). Phosphorylation of PKB/Akt was most
apparent in alveolar epithelial cells, with markedly less
activation in ductal epithelium (not shown). Western blot
Figure 6. OPGL Promotes Alveolar Epithelial Proliferation and Sur-
analyses confirmed that phospho-PKB/Akt was presentvival
in wild type mammary glands during pregnancy and(A–D) Impaired proliferation of alveolar epithelium in opgl2/2 mam-
at L1, but undetectable in nonpregnant females (notmary glands as detected by in situ PCNA immunostaining. (A and
shown). In contrast, although total PKB/Akt protein ex-C) opgl2/2 mammary tissue implanted with a control pellet at P14.5
exhibits few proliferating epithelial cells in alveolar buds (arrow- pression was normal in mammary tissues from pregnant
heads) at L1. (B and D) Contralateral tissue of the same mouse as opgl2/2 females (Figure 7C), active phospho-PKB/Akt
in (A) and (C) implanted with rOPGL [10mg/pellet] at P14.5 displays was completely absent both at P14.5 (not shown) and
induction of lobulo-alveolar structures with rescued proliferation of L1 (Figure 7D). In contrast to defective PKB/Akt acti-alveolar epithelial cells (arrowheads) at L1. (C) and (D) are magnifica-
vation, in vivo activation of ERK1/ERK2, STAT3, andtions of (A) and (B), respectively.
STAT5A/B (as detected by Abs reactive to phosphoryla-(E–G) Increased mammary epithelial cell apoptosis in the absence
of OPGL, as detected by confocal microscopy of Hoechst stained tion-specific epitopes indicative of activation) was pre-
cells. (E) Apoptotic nuclei (arrows) are apparent at L1 in epithelial served in mammary epithelial cells of opgl2/2 females at
cells of developing alveoli in mammary tissue isolated from opgl2/2 P14.5 and L1 (not shown). Thus, the loss of OPGL leads
females implanted with a control pellet. (F) Contralateral tissue of to impaired PKB/Akt activation in alveolar mammarythe same mouse as in (E) implanted with rOPGL [10 mg/pellet]. No
epithelial cells.apoptotic nuclei are detectable in the developing lobulo-alveolar
We next determined whether the reintroduction ofstructure at L1. (G) Quantification of ductal and alveolar epithelial
apoptosis at L1. A minimum of 1000 nuclei of ductal and alveolar OPGL expression could restore PKB/Akt activation in
epithelial cells was counted for each sample. Results shown are opgl2/2 mammary epithelium. Whereas implantation of
of individual mammary tissues. For (E)–(G), apoptotic nuclei were control pellets did not rescue PKB/Akt phosphorylation
detected by confocal microscopy and cell death confirmed by in (Figure 7E), implantation of rOPGL was able to inducesitu DNA end-labeling. Scale bars: (A) and (B), 0.1 mm; (C) and (D),
PKB/Akt activation in alveolar epithelium (Figure 7F).50 mm. Magnification in (E) and (F) 4003.
Total PKB/Akt levels were not affected by implantation
Cell
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In phylogenetic evolution, the formation of lactating
mammary glands is a relatively recent event, occurring
when the first mammals appeared about 200 million
years ago. Thus, mammals took a gene product that is
the master regulator of bone metabolism and calcium
turnover in the whole organism and subverted it to stim-
ulation of mammary gland development during preg-
nancy.
Our results indicate that pregnancy hormones induce
OPGL expression in mammary epithelial cells, and that
OPGL acts through RANK to deliver proliferative and
survival signals that promote the development of lobulo-
alveolar structures and the formation of a lactating mam-
mary gland. Various factors have been implicated at
distinct stages in the differentiation and involution of
mammary epithelial structures, including estrogen, pro-
lactin, progesterone, Wnt4, Stat5a, cyclin D1, or Csf-1
(Pollard and Hennighausen, 1994; Liu et al., 1997; Nev-
ille, 1999; Gouon-Evans et al., 2000; Robinson et al.,
2000). Hormonal regulation of OPGL expression sug-
gests that at least some of these molecules might medi-
ate their effects on mammary gland development in
pregnancy via OPGL. During pregnancy, progesterone
and the progesterone receptor are required for the de-
velopment of the ductal tree and subsequent ductal
branching (Couse and Korach, 1998). These early effects
of progesterone have been genetically linked to Wnt4
signaling (Brisken et al., 2000). However, in later stages
Figure 7. Impaired PKB/Akt Phosphorylation in opgl2/2 Mammary of pregnancy, wnt42/2 mammary glands resemble wild-
Tissue type glands and form normal lobulo-alveolar structures.
(A–D) Expression of (A and C) total PKB/Akt and (B and D) activated Since OPGL expression is strongly induced by proges-
PKB/Akt (phosphorylated Ser473, P-PKB) in mammary tissue of (A terone, it is possible that the later effects of progester-
and B) wild-type and (C and D) opgl2/2 females at L1. Total and one on alveolar differentiation could be mediated by
activated PKB were visualized by in situ immunohistochemistry.
OPGL-RANK. Consistent with this scenario, femaleNote the complete absence of activated PKB in opgl2/2 epithelium
opgl2/2 and rank2/2 mice display normal ductal elonga-(D). Similar results were obtained with tissue at different stages of
tion and ductal outgrowth during puberty and normalpregnancy.
(E and F) Restoration of PKB/Akt activation in developing lobulo- side branching and ductal responses to hormones dur-
alveolar epithelium of pregnant opgl2/2 females by rOPGL adminis- ing early pregnancy. In addition, opgl2/2 and rank2/2 mice
tration. Control pellets (E) and pellets containing rOPGL [10 mg/ display normal luteinization and ovulation, unlike pro-
pellet] (F) were implanted into contralateral mammary fat pads of gesterone receptor- or prolactin receptor-deficient mice
opgl2/2 females at P14.5. Sections were analyzed by immunohisto-
(Lydon et al., 1995; Ormandy et al., 1997). During preg-chemistry at L1. Data are representative of six mice in three experi-
nancy, csf-12/2 (op/op) mice show impaired ductalments. Inserts in (A)–(F) show lower magnification. Scale bars:
sprouting, but increased lobulo-alveolar development(A)–(F), 50 mm; inserts in (A)–(F), 0.1 mm.
of mammary epithelium and expression of milk proteins
(Pollard and Hennighausen, 1994). On the other hand,
OPGL has no apparent role in ductal sprouting but OPGLof rOPGL (not shown). These data indicate that in vivo
is essential for lobulo-alveolar development during ges-activation of PKB/Akt, but not activation of ERK, STAT3,
tation. Similar to the synergy between CSF-1 and OPGLand STAT5A/B, in mammary epithelial cells appears to
in osteoclastogenesis, it appears that CSF-1 regulatesbe dependent on the OPGL/RANK pathway.
ductal sprouting which is followed by OPGL-dependent
lobulo-alveolar development. Thus, OPGL and RANK
Discussion appear to be involved only in the terminal differentiation
of alveolar cells in late pregnancy.
Our results show that OPGL and its receptor RANK, Using rank knockout animals, it has been shown that
the two critical molecules for osteoclast development/ essentially all factors that inhibit or enhance bone re-
activation and skeletal calcium release, are also essen- sorption and calcium mobilization via osteoclasts in vitro
tial for the formation of a lactating mammary gland, the and in vivo, including IL-1b, dexamethasone, or PTHrP,
organ required to provide essential nourishment and act via regulation of OPGL-RANK (Li et al., 2000). CSF-1
calcium to offspring in mammalian species. Osteoclast- and OPGL cooperate to stimulate the differentiation of
mediated skeletal demineralization is the principal mech- hematopoietic progenitors into mature multinucleated
anism by which lactating mammals meet the calcium osteoclasts (Lacey et al., 1998). It is thought that CSF-1
demands of newborns, and calcium transport from provides the initial survival signal for myeloid/osteoclast
mothers to the fetus and neonates is a vital process to progenitors that is followed by the action of OPGL, the
critical factor for osteoclast lineage determination (La-preserving the species (Kovacs and Kronenberg, 1997).
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gasse and Weissman, 1997). Thus, the complex system quired for transmission of maternal calcium to neonates
in mammalian species.of osteoclast-regulated bone remodeling is ultimately
controlled by OPGL-RANK. We now report the surpris-
Experimental Proceduresing finding that OPGL and RANK, the master regulators
of skeletal calcium release and bone remodeling, are
Mice
essential for the formation of the lactating mammary Mice genetically deficient for opgl, rank, or rag1 have been de-
gland, the organ required for transmission of maternal scribed previously (Kong et al., 1999a; Li et al., 2000). For timed
calcium to neonates in mammalian species. Similar to pregnancies, male and female mice were mated overnight and fe-
male mice were scored for vaginal plaques the next morning. Thethe regulation of osteoclasts, OPGL-RANK could be the
presence of vaginal plaques was taken to represent pregnancy dayessential mediators downstream of multiple factors
0.5 (P0.5). All mouse strains used were of the C57BL/6 backgroundknown to affect lobulo-alveolar differentiation. Impor-
(H-2b/b). It should be noted that in all experiments opgl1/2 and rank1/2
tantly, our data provide a novel paradigm in mammary mice displayed a mammary gland phenotype that was indistinguish-
gland biology and define a novel functional signaling able to that of wild-type mice. All mice were maintained at the animal
pathway involved in lobulo-alveolar development. facilities of the Ontario Cancer Institute and Amgen.
The balance between OPGL, RANK, and the decoy
Histology, Whole-Mount, and Immunohistochemistryreceptor OPG is critical for the regulation of bone loss
For histological analysis, 5 mm sections were cut and stained within osteoporosis, arthritis, and lytic bone metastases
hematoxylin and eosin (H&E). Whole-mount staining of mammary
(Karsenty, 1999). Osteoporosis affects hundreds of mil- glands was performed as described (Fata et al., 1999). For immuno-
lions of people, particularly postmenopausal women. peroxidase staining, paraffin-embedded sections were dehydrated
Intriguingly, genetic and functional models have shown and antigenic epitopes exposed using a 10 mM citrate buffer and
microwaving. Sections were incubated with rabbit polyclonal Absthat osteoclast-regulated bone remodeling is under the
to PKB/Akt, phospho-PKB/Akt (Ser473), phospho-ERK1/ERK2control of powerful sex and pregnancy hormones (Ross,
(Thr202/Tyr204), phospho-Stat3 (Y705), phospho-Stat5A/B (Y694)2000). When estrogen production falls, such as occurs
(New England Biolabs), and mouse monoclonal anti-PCNA (Santa
in ovarectomy models in animals or in postmenopausal Cruz Biotech), and visualized using peroxidase-conjugated second-
women, induction of OPG is decreased, allowing uncon- ary antibodies. Apoptotic cells were determined either by in situ
trolled demineralization of bone by OPGL-stimulated DNA end-labeling or Hoechst staining and confocal microscopy.
Histomorphometric indices (proliferation and apoptosis) were calcu-osteoclasts (Simonet et al., 1997). Osteoporosis is
lated as the number of positive epithelial cells divided by the totalstrongly associated with increased morbidity and pre-
number of epithelial cells, with no fewer than 1000 nuclei countedmature death in older women. The evolutionary question
per section.
then arises, why has the OPGL/RANK/OPG system, a
key regulator of a structural organ such as the skeleton, In Situ Hybridizations and RNA Analysis
come under the regulatory umbrella of reproductive hor- In situ hybridizations were performed on 4% formalin fixed mam-
mary sections. Strand-specific riboprobes for opgl and rank weremones? Our results provide a molecular and evolution-
generated by incorporating digoxygenin (DIG)-labeled UTP or [35S]-ary explanation for gender bias and high incidence of
UTP. In situ hybridization using DIG-UTP or 35S-UTP labeled senseosteoporosis in females. The strong bias toward bone
and antisense opgl and rank probes have been described previouslyloss in postmenopausal women may be due to the fact
(Lacey et al., 1998; Hsu et al., 1999). Northern analysis for b-casein
that the OPG/RANK/OPG system is essential for repro- and keratin 18 mRNA was performed on 20 mg total mammary RNA.
duction and the survival of mammalian offspring.
Mammary Tissue Manipulations and Transplants
Elvax-40 pellets (Dupont) containing rOPGL were prepared as de-Conclusions
scribed (Fata et al., 1999). All OPGL and control pellets were surgi-OPGL is the key regulator of skeletal calcium resorption
cally implanted into the fourth inguinal mammary fat pad distal to
and osteoclasts development/activation. We report the the lymph node. For transplantation studies, mammary epithelial
surprising finding that OPGL is essential for the forma- tissue was isolated from nulliparous 3-week-old donors and im-
tion of a lactating mammary gland. Female opgl gene- planted into cleared mammary fat pads (devoid of endogenous epi-
thelium) of 3-week-old host rag12/2 mice. Three weeks after surgery,deficient mice have a complete block in the formation of
hosts were mated and mammary tissue was isolated for analysis.lobulo-alveolar mammary structures during pregnancy
Bilateral ovarectomies (OVX) were performed on anesthesizedwhich leads to neonatal death of newborns. The TNF-
4-week-old female mice. Mammary tissue from female mice injected
Receptor family protein RANK was identified as the criti- with 17-b-estradiol (Sigma; 10 mg/ml; 50 ml s.c. at 0 and 8 hr post-
cal receptor of this OPGL action. OPGL expression in OVX), progesterone (Sigma; 10 mg/ml; 50 ml s.c. at 0, 8 hr post-
mammary epithelial cells is induced by pregnancy hor- OVX), prolactin (Sigma; 20 mg/ml; 50 ml i.p. at 0, 8, 16 hr post-OVX),
and PTHrP (Sigma; 400 mg/ml; 30 ml s.c. at 0, 8, 16 hr post-OVX)mones whereas RANK is constitutively expressed on
were collected at 24 hr post-OVX.mammary epithelial cells. Transplantation and OPGL-
rescue experiments in opgl2/2 and rank2/2 pregnant fe-
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